Yu H - Search Results

1

Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials.

Pathak R, De Lima Lopes G, Yu H, Aryal MR, Ji W, Frumento KS, Wallis CJD, Klaassen Z, Park HS, Goldberg SB. Pathak R, et al. Among authors: yu h. Cancer. 2021 Mar 1;127(5):709-719. doi: 10.1002/cncr.33269. Epub 2020 Oct 29. Cancer. 2021. PMID: 33119177 Free article.

2

Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world.

Aryal MR, Gosain R, Donato A, Yu H, Katel A, Bhandari Y, Dhital R, Kouides PA. Aryal MR, et al. Among authors: yu h. Blood Adv. 2019 Aug 13;3(15):2381-2387. doi: 10.1182/bloodadvances.2019000572. Blood Adv. 2019. PMID: 31405948 Free PMC article.

3

Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysis.

Giri S, Aryal MR, Yu H, Grimshaw A, Pathak R, Huntington SP, Dhakal B. Giri S, et al. Among authors: yu h. J Geriatr Oncol. 2020 Nov;11(8):1285-1292. doi: 10.1016/j.jgo.2020.05.013. Epub 2020 Jun 5. J Geriatr Oncol. 2020. PMID: 32513568 Free PMC article.

4

Post-Operative Outcomes of Pre-Thoracic Surgery Respiratory Muscle Training vs Aerobic Exercise Training: A Systematic Review and Network Meta-analysis.

Kunadharaju R, Saradna A, Ray A, Yu H, Ji W, Zafron M, Mador MJ. Kunadharaju R, et al. Among authors: yu h. Arch Phys Med Rehabil. 2023 May;104(5):790-798. doi: 10.1016/j.apmr.2022.10.015. Epub 2022 Dec 17. Arch Phys Med Rehabil. 2023. PMID: 36539175 Review.

5

Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy.

Huang K, Prasad S, Ma SJ, Yu H, Iovoli AJ, Farrugia MK, Dexter EU, Demmy TL, Malik NK, Singh AK. Huang K, et al. Among authors: yu h. BMC Cancer. 2023 Mar 18;23(1):254. doi: 10.1186/s12885-023-10719-3. BMC Cancer. 2023. PMID: 36932396 Free PMC article.

6

ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms.

Awada H, Bhatta M, Yu H, Ji W, Hou S, Cronin T, Ba Aqeel S, Roy AM, Faisal MS, Kouides P, Mascarenhas J, Griffiths EA, Elshoury A. Awada H, et al. Among authors: yu h. Leukemia. 2024 Jan;38(1):210-214. doi: 10.1038/s41375-023-02069-7. Epub 2023 Nov 3. Leukemia. 2024. PMID: 37919607 No abstract available.

7

Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process.

Yeary KHK, Clark N, Saad-Harfouche F, Erwin D, Kuliszewski MG, Li Q, McCann SE, Yu H, Lincourt C, Zoellner J, Tang L. Yeary KHK, et al. Among authors: yu h. JMIR Cancer. 2022 Feb 15;8(1):e32291. doi: 10.2196/32291. JMIR Cancer. 2022. PMID: 35166681 Free PMC article.

8

Sweet Beverages and Cancer: A Scoping Review of Quantitative Studies.

Yeary KHK, Quisenberry AJ, Hall MG, Yu H, Henry WAE, Rodriguez EM, Zoellner JM. Yeary KHK, et al. Among authors: yu h. Cancer Prev Res (Phila). 2022 Jun 2;15(6):377-390. doi: 10.1158/1940-6207.CAPR-21-0507. Cancer Prev Res (Phila). 2022. PMID: 35271710 Review.

9

Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stage I-II pancreatic cancer.

Ma SJ, Serra LM, Bartl AJ, Han HR, Fekrmandi F, Iovoli AJ, Hermann GM, Yu H, Singh AK. Ma SJ, et al. Among authors: yu h. J Radiother Pract. 2022 Sep;21(3):383-392. doi: 10.1017/s1460396921000194. Epub 2021 Apr 14. J Radiother Pract. 2022. PMID: 36016861 Free PMC article.

10

Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.

Oliver L, Alvarez R, Diaz R, Valdés A, Colligan SH, Nemeth MJ, Twum DYF, Fernández A, Fernández-Medina O, Carlson LM, Yu H, Eng KH, Hensen ML, Rábade-Chediak ML, Fernández LE, Lee KP, Perez L, Muhitch JB, Mesa C, Abrams SI. Oliver L, et al. Among authors: yu h. J Immunother Cancer. 2022 Sep;10(9):e004710. doi: 10.1136/jitc-2022-004710. J Immunother Cancer. 2022. PMID: 36150744 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,571 results

Search Page